Dose antispasmodic agents administration at the cecum in the colon increase adenoma detection rates by colonoscopy ? : a randomized double-blind placebo-controlled trial

Dose antispasmodic agents administration at the cecum in the colon increase adenoma detection rates by colonoscopy ? : a randomized double-blind placebo-controlled trial - The effect of antispasmodic agents for the adenoma detection by colonosocpy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018152

Enrollment

200

Registered

2015-07-01

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic adenoma

Interventions

Antispasmodic agents administration Normal saline administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Inpatients and outpatients of Sentohiru hospital who have the positive of fecal occult blood test or clinical symptoms (Ex: hematochesia, abdominal pain, constipation). 2) Inpatients and outpatients of Sentohiru hospital who are scheduled to examine the colon for polyp surveillance.

Exclusion criteria

Exclusion criteria: 1.Patients with ileus. 2.Pregnant and lactating patients. 3.Patients after the colectomy. 4.Patients with colon cancer. 5.Patients with inflammatory bowel disease 6.Patients with FAP or HNPCC 7.Patients who judged inappropriate for clinical trial for severe comorbidity. 8.Patients with DM and Ischemic heart disease or BPH or Glaucoma.

Design outcomes

Primary

Measure	Time frame
Adenoma detection rate of the colon	—

Secondary

Measure	Time frame
Side effects of antispasmodic agents	—

Countries

Japan

Contacts

Public ContactMineko Nagasaki

Sentohiru Hospital Respiratory division

nishikiwa@sthill-hp.or.jp0836-51-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026